Close

Heat Biologics (HTBX) Suspends Proposed Offering of Common Stock; to Explore Alternative Options

Go back to Heat Biologics (HTBX) Suspends Proposed Offering of Common Stock; to Explore Alternative Options

Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock

July 22, 2016 8:01 AM EDT

DURHAM, N.C., July 22, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Heat) (Nasdaq: HTBX), an immuno-oncology company developing novel therapies that activate a patients immune system against cancer, announced that the company has suspended the proposed public offering of shares of its common stock previously announced on July 21, 2016.  Heats leadership team decided to suspend the proposed public offering to explore alternative options presented to the... More

Heat Biologics Announces Proposed Public Offering of Common Stock

July 21, 2016 4:15 PM EDT

DURHAM, N.C., July 21, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Heat) (Nasdaq: HTBX), an immuno-oncology company developing novel therapies that activate a patients immune system against cancer, announced today that it has commenced an underwritten public offering of shares of its common stock.  All of the shares in the offering are to be sold by Heat.  Heat... More